Glucocorticoid receptors are required for up‐regulation of neuronal 5‐lipoxygenase (5LOX) expression by dexamethasone
dc.contributor.author | Uz, Tolga | |
dc.contributor.author | Dwivedi, Yogesh | |
dc.contributor.author | Qeli, Albi | |
dc.contributor.author | Peters-Golden, Marc | |
dc.contributor.author | Pandey, Ghanshyam | |
dc.contributor.author | Manev, Hari | |
dc.date.accessioned | 2020-03-17T18:29:38Z | |
dc.date.available | 2020-03-17T18:29:38Z | |
dc.date.issued | 2001-08 | |
dc.identifier.citation | Uz, Tolga; Dwivedi, Yogesh; Qeli, Albi; Peters-Golden, Marc; Pandey, Ghanshyam; Manev, Hari (2001). "Glucocorticoid receptors are required for up‐regulation of neuronal 5‐lipoxygenase (5LOX) expression by dexamethasone." The FASEB Journal 15(10): 1792-1794. | |
dc.identifier.issn | 0892-6638 | |
dc.identifier.issn | 1530-6860 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/154349 | |
dc.description.abstract | 5‐lipoxygenase (5LOX) is the key enzyme in the synthesis of leukotrienes from arachidonic acid. Hyperglucocorticoidemia, dexamethasone, and aging up‐regulate 5LOX in the brain, including the cerebellum in vivo. We studied the mechanisms of dexamethasone‐triggered 5LOX up‐regulation in primary cultures of rat cerebellar granule neurons (CGN). We measured 5LOX mRNA and protein contents, and the formation of cysteinyl leukotrienes (LTC4, LTD4, and LTE4). The dexamethasone (0.1 μM or 1 μM)‐increased 5LOX mRNA and protein contents were already observed at 3 h of treatment, and they persisted for at least 24 h. Dexamethasone also increased the content of cysteinyl leukotrienes, assayed in the presence of 2 μM calcium ionophore A23187 and 10 μM arachidonic acid. The stimulatory effect of dexamethasone on 5LOX expression was inhibited by the glucocorticoid receptor (GR) antagonist RU486 and by reducing the CGN content of GR receptor protein with a GR‐specific antisense oligonucleotide. The 5LOX mRNA half‐life was longer in dexamethasone than in vehicle‐treated CGNs. Our results indicate that dexamethasone increases 5LOX expression in CGNs in a GR‐dependent manner and that it also increases the stability of 5LOX mRNA. Further studies are warranted to elucidate the physiologic/pathologic significance of glucocorticoid‐regulated expression of 5LOX in the central nervous system. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Federation of American Societies for Experimental Biology | |
dc.subject.other | leukotrienes | |
dc.subject.other | cerebellar granule neurons | |
dc.subject.other | cerebellar granule neurons | |
dc.subject.other | arachidonic acid | |
dc.title | Glucocorticoid receptors are required for up‐regulation of neuronal 5‐lipoxygenase (5LOX) expression by dexamethasone | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biology | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154349/1/fsb2fj000836fje-sup-0001.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154349/2/fsb2fj000836fje.pdf | |
dc.identifier.doi | 10.1096/fj.00-0836fje | |
dc.identifier.source | The FASEB Journal | |
dc.identifier.citedreference | Paek I., Axel R. ( 1987 ) Glucocorticoids enhance stability of human growth hormone mRNA. Mol. Cell Biol. 7, 1496 – 1507 | |
dc.identifier.citedreference | Santi, M. R., Ikonomovic, S., Wroblewski, J. T., Grayson, D. R. ( 1994 ) Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro. J. Neurochem. 63, 1207 – 1217 | |
dc.identifier.citedreference | Pshenichkin, S. P., Wise, B. C. ( 1995 ) Okadaic acid increases nerve growth factor secretion, mRNA stability, and gene transcription in primary cultures of cortical astrocytes. J. Biol. Chem. 270, 5994 – 5999 | |
dc.identifier.citedreference | Peters-Golden, M., Shelly, C., Morganroth, M. L. ( 1989 ) Inhibition of rat lung glutathione synthesis attenuates hypoxic pulmonary vasoconstriction and the associated leukotriene C4 production. Am. Rev. Respir. Dis. 140, 1210 – 1215 | |
dc.identifier.citedreference | Xu, Z. X., Rooney, S. A. ( 1997 ) Glucocorticoids increase fatty-acid synthase mRNA stability in fetal rat lung. Am. J. Physiol. 272, L860 – L864 | |
dc.identifier.citedreference | de Kloet, E. R., Oitzl, M. S., Joels, M. ( 1999 ) Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci. 22, 422 – 426 | |
dc.identifier.citedreference | Birmingham, M. K., Sar, M., Stumpf, W. E. ( 1993 ) Dexamethasone target sites in the central nervous system and their potential relevance to mental illness. Cell. Mol. Neurobiol. 13, 373 – 386 | |
dc.identifier.citedreference | Ahima, R. S., Harlan, R. E. ( 1991 ) Differential corticosteroid regulation of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system: topography and implications. Endocrinology 129, 226 – 236 | |
dc.identifier.citedreference | Marlier, L. N., Patacchioli, F. R., Porzio, O., Chiusaroli, R., Borboni, P., Lauro, R., Angelucci, L. ( 1997 ) Distribution of adrenocorticoid receptors in the rat CNS measured by competitive PCR and cytosolic binding. J. Mol. Neurosci. 9, 1 – 12 | |
dc.identifier.citedreference | Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., Logsdon, C. D. ( 1988 ) Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J. Biol. Chem. 263, 2581 – 2584 | |
dc.identifier.citedreference | Cadepond, F., Ulmann, A., Baulieu, E. E. ( 1997 ) RU486 (mifepristone): mechanisms of action and clinical uses. Annu. Rev. Med. 48, 129 – 156 | |
dc.identifier.citedreference | Moore, F. L., Evans, S. J. ( 1999 ) Steroid hormones use non-genomic mechanisms to control brain functions and behaviors: a review of evidence. Brain Behav. Evol. 54, 41 – 50 | |
dc.identifier.citedreference | Steinhilber, D., Brungs, M., Werz, O., Wiesenberg, I., Danielsson, C., Kahlen, J. P., Nayeri, S., Schrader, M., Carlberg, C. ( 1995 ) The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270, 7037 – 7040 | |
dc.identifier.citedreference | Poon, M., Liu, B., Taubman, M. B. ( 1999 ) Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. Mol. Cell Biol. 19, 6471 – 6478 | |
dc.identifier.citedreference | Hines, D., Hug, V., Levy, J. R. ( 1994 ) Dexamethasone mediated stabilization of insulin receptor mRNA. J. Recept. Res. 14, 297 – 305 | |
dc.identifier.citedreference | Wickens, M., Anderson, P., Jackson, R. J. ( 1997 ) Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7, 220 – 232 | |
dc.identifier.citedreference | Qu, T., Uz, T., Manev, H. ( 2000 ) Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol. Aging. 21, 647 – 652 | |
dc.identifier.citedreference | Ohtsuki, T., Matsumoto, M., Hayashi, Y., Yamamoto, K., Kitagawa, K., Ogawa, S., Yamamoto, S., Kamada, T. ( 1995 ) Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am. J. Physiol. 268, H1249 – H1257 | |
dc.identifier.citedreference | Rao, A. M., Hatcher, J. F., Kindy, M. S., Dempsey, R. J. ( 1999 ) Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem. Res. 24, 1225 – 1232 | |
dc.identifier.citedreference | Qu, T., Manev, R., Manev, H. ( 2001 ) 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early and late onset Alzheimer’s disease. J. Neuropsych. Clin. Neurosci. | |
dc.identifier.citedreference | Chabot, C., Gagne, J., Giguere, C., Bernard, J., Baudry, M., Massicotte, G. ( 1998 ) Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus 8, 299 – 309 | |
dc.identifier.citedreference | Vaughan, C. W., Ingram, S. L., Connor, M. A., Christie, M. J. ( 1997 ) How opioids inhibit GABA-mediated neurotransmission. Nature (London) 390, 611 – 614 | |
dc.identifier.citedreference | Manev, H., Uz, T., Manev, R. ( 2000 ) Putative role of neuronal 5-lipoxygenase (5-LOX) in proliferation of immature cerebellar granule cells. J. Neurochem. 74, S64 | |
dc.identifier.citedreference | Mayatepek, E. ( 2000 ) Leukotriene C 4 synthesis deficiency: a member of a probably underdiagnosed new group of neurometabolic diseases. Eur. J. Pediatr. 159, 811 – 818 | |
dc.identifier.citedreference | Ahlbom, E., Gogvadze, V., Chen, M., Celsi, G., Ceccatelli, S. ( 2000 ) Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc. Natl. Acad. Sci. USA 97, 14726 – 14730 | |
dc.identifier.citedreference | Sapolsky, R. M. ( 2000 ) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925 – 935 | |
dc.identifier.citedreference | Peters-Golden, M. ( 1998 ) Molecular mechanisms of leukotriene synthesis: the changing paradigm. Clin. Exp. Allergy 28, 1059 – 1065 | |
dc.identifier.citedreference | Simmet, T., Tippler, B. ( 1991 ) On the relation between cerebral cysteinyl-leukotriene formation and epileptic seizures. Brain Res. 540, 283 – 286 | |
dc.identifier.citedreference | Heise, C. E., O’Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D. S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., Williams, D. L. Jr., Zeng, Z., Liu, Q., Ma, L., Clements, M. K., Coulombe, N., Liu, Y., Austin, C. P., George, S. R., O’Neill, G.P., Metters, K. M., Lynch, K. R., Evans, J. F. ( 2000 ) Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275, 30531 – 30536 | |
dc.identifier.citedreference | Manev, H., Uz, T., Sukaya, K., Qu, T. ( 2000 ) Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 14, 1464 – 1469 | |
dc.identifier.citedreference | Paris, D., Town, T., Parker, T., Humphrey, J., Mullan, M. ( 2000 ) A beta vasoactivity: an inflammatory reaction. Ann. N. Y. Acad. Sci. 903, 97 – 109 | |
dc.identifier.citedreference | Manev, H. ( 2000 ) 5-Lipoxygenase gene polymorphism and onset of Alzheimer’s disease. Med. Hypotheses 54, 75 – 76 | |
dc.identifier.citedreference | Uz, T., Dwivedi, Y., Savani, P. D., Impagnatiello, F., Pandey, G., Manev, H. ( 1999 ) Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J. Neurochem. 73, 693 – 699 | |
dc.identifier.citedreference | Magri, F., Terenzi, F., Ricciardi, T., Fioravanti, M., Solerte, S. B., Stabile, M., Balza, G., Gandini, C., Villa, M., Ferrari, E. ( 2000 ) Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia. Dement. Geriatr. Cogn. Disord. 11, 90 – 99 | |
dc.identifier.citedreference | Colamorea, T., Di Paola, R., Macchia, F., Guerrese, M. C., Tursi, A., Butterfield, J. H., Caiaffa, M. F., Haeggstrom, J. Z., Macchia, L. ( 1999 ) 5-Lipoxygenase upregulation by dexamethasone in human mast cells. Biochem. Biophys. Res. Commun. 265, 617 – 624 | |
dc.identifier.citedreference | Riddick, C. A., Ring, W. L., Baker, J. R., Hodulik, C. R., Bigby T. D. ( 1997 ) Related Articles Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246, 112 – 118 | |
dc.identifier.citedreference | Lammers, C. H., Schweitzer, P., Facchinetti, P., Arrang, J. M., Madamba, S. G., Siggins, G. R., Piomelli, D. ( 1996 ) Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J. Neurochem. 66, 147 – 152 | |
dc.identifier.citedreference | Manev, H., Uz, T. ( 1999 ) Primary cultures of rat cerebellar granule cells as a model to study neuronal 5-lipoxygenase and FLAP gene expression. Ann. N. Y. Acad. Sci. 890, 183 – 190 | |
dc.identifier.citedreference | Sanchez, M. M., Young, L. J., Plotsky, P. M., Insel, T. R. ( 2000 ) Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 20, 4657 – 4668 | |
dc.identifier.citedreference | Morimoto, M., Morita, N., Ozawa, H., Yokoyama, K., Kawata, M. ( 1996 ) Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 26, 235 – 269 | |
dc.identifier.citedreference | Korte, S. M., De Kloet, E. R., Buwalda, B., Bouman, S. D., Bohus, B. ( 1996 ) Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Eur. J. Pharmacol. 301, 19 – 25 | |
dc.identifier.citedreference | Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., Rutter, W. J. ( 1979 ) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294 – 5299 | |
dc.identifier.citedreference | Uz, T., Longone, P., Manev, H. ( 1997 ) Increased hippocampal 5-lipoxygenase mRNA content in melatonin-deficient, pinealectomized rats. J. Neurochem. 69, 2220 – 2223 | |
dc.identifier.citedreference | Uz, T., Pesold, C., Longone, P., Manev, H. ( 1998 ) Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J. 12, 439 – 449 | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.